Guizhi fuling wan as a novel agent for intravesical treatment for bladder cancer in a mouse model

Molecular Medicine

Volumn 22, Issue , 2016, Pages 64-73

  Lu, Chi Chen ^a,b   Shen, Cheng Huang ^a   Chang, Chia Bin ^b   Hsieh, Hsiao Yen ^a,b   Wu, Jiann Der ^a   Tseng, Ling Huei ^b   Hwang, Dennis W ^b   Chen, Syue Yi ^a   Wu, Shu Fen ^b   Chan, Michael W Y ^b   Hsu, Cheng Da ^a,b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BCG VACCINE; CHECKPOINT KINASE 2; GUIZHI FULING WAN; HERBACEOUS AGENT; MITOMYCIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HEMATURIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 84987644101     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00085     Document Type: Article

References (45)

1. Roupret M, et al. (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur. Urol. 59:584-94.
2. Shen CH, et al. (2010) Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model. Br. J. Pharmacol. 160:2008-27.
3. Jacobs BL, Lee CT, Montie JE. (2010) Bladder cancer in 2010: how far have we come? CA Cancer J. Clin. 60:244-72.
4. Damrauer JS, et al. (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. U. S. A. 111:3110-5.
5. Herr HW. (1997) Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J. Urol. 15:84-8.
6. Hall MC, et al. (2007) Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J. Urol. 178:2314-30.
7. Barocas DA, Clark PE. (2008) Bladder cancer. Cur. Opin. Oncol. 20:307-14.
8. Ulker V, Apaydin E, Gursan A, Ozyurt C, Kandiloglu G. (1996) Eosinophilic cystitis induced by mitomycin-C. Int. Urol. Nephrol. 28:755-9.
9. Lopez-Beltran A, Luque RJ, Mazzucchelli R, Scarpelli M, Montironi R. (2002) Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J. Clin. Pathol. 55:641-7.
10. Hidoussi A, et al. (2007) Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation. Urology. 70:591. e599-10.
11. Betz SA, See WA, Cohen MB. (1993) Granulomatous inflammation in bladder wash specimens after intravesical bacillus Calmette-Guerin therapy for transitional cell carcinoma of the bladder. Am. J. Clin. Pathol. 99:244-8.
12. Park WH, Joo ST, Park KK, Chang YC, Kim CH. (2004) Effects of the Geiji-Bokryung-Hwan on carrageenan-induced inflammation in mice and cyclooxygenase-2 in hepatoma cells of HepG2 and Hep3B. Immunopharmacol. Immunotoxicol. 26:103-12.
13. Park WH, Lee SK, Oh HK, Bae JY, Kim CH. (2005) Tumor initiation inhibition through inhibition COX-1 activity of a traditional Korean herbal prescription, Geiji-Bokryung-Hwan, in human hepatocarcinoma cells. Immunopharmacol. Immunotoxicol. 27:473-83.
14. Yao Z, Shulan Z. (2008) Inhibition effect of Guizhi-Fuling-decoction on the invasion of human cervical cancer. J. Ethnopharmacol. 120:25-35.
15. Lu CC, et al. (2013) The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder. BMC Complement. Altern. Med. 13:44.
16. Li Q, et al. (2011) SFE-CO2 extract from Typhonium giganteum Engl. tubers, induces apoptosis in human hepatoma SMMC-7721 cells involvement of a ROS-mediated mitochondrial pathway. Molecules. 16:8228-42.
17. Chen J, Wong HS, Ko KM. (2014) Ursolic acid-enriched herba cynomorii extract induces mitochondrial uncoupling and glutathione redox cycling through mitochondrial reactive oxygen species generation: protection against menadione cytotoxicity in h9c2 cells. Molecules. 19:1576-91.
18. Duan D, Zhang B, Yao J, Liu Y, Fang J. (2014) Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Free Radic. Biol. Med. 70:182-93.
19. Fridovich I. (1999) Fundamental aspects of reactive oxygen species, or what’s the matter with oxygen? Ann. N. Y. Acad. Sci. 893:13-8.
20. Fang YZ, Yang S, Wu G. (2002) Free radicals, antioxidants, and nutrition. Nutrition. 18:872-9.
21. Macip S, et al. (2003) Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23:8576-85.
22. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. (2010) ATM activation by oxidative stress. Science. 330:517-21.
23. Chatterjee S, Kundu S, Sengupta S, Bhattacharyya A. (2009) Divergence to apoptosis from ROS induced cell cycle arrest: effect of cadmium. Mutat. Res. 663:22-31.
24. Imlay JA, Chin SM, Linn S. (1988) Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science. 240:640-2.
25. Maynard S, Schurman SH, Harboe C, de SouzaPinto NC, Bohr VA. (2009) Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis. 30:2-10.
26. Wiseman H, Halliwell B. (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:17-29.
27. Levine RL. (2002) Carbonyl modified proteins in cellular regulation, aging, and disease. Free Rad. Biol. Med. 32:790-6.
28. Wells-Knecht MC, Lyons TJ, McCance DR, Thorpe SR, Baynes JW. (1997) Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes: evidence against a generalized increase in oxidative stress in diabetes. J. Clin. Invest. 100:839-46.
29. Qanungo S, Das M, Haldar S, Basu A. (2005) Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis. 26:958-67.
30. Zhang R, Humphreys I, Sahu RP, Shi Y, Srivastava SK. (2008) In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis. 13:1465-78.
31. Sahu RP, Zhang R, Batra S, Shi Y, Srivastava SK. (2009) Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis. 30:1744-53.
32. Kubota S, et al. (2014) Activation of the pre-replication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage. J. Biol. Chem. 289:5730-46.
33. Chen Y, Poon RY. (2008) The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Front. Biosci. 13:5016-29.
34. Smith J, Tho LM, Xu N, Gillespie DA. (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 108:73-112.
35. Bisteau X, et al. (2013) CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. PLoS Genet. 9:e1003546.
36. Nikitin PA, Price AM, McFadden K, Yan CM, Luftig MA. (2014) Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest. PLoS One. 9:e87299.
37. Xie G, et al. (1998) Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. Oncogene. 16:721-36.
38. Hartwell LH, Kastan MB. (1994) Cell cycle control and cancer. Science. 266:1821-8.
39. Vermeulen K, Berneman ZN, Van Bockstaele DR. (2003) Cell cycle and apoptosis. Cell Prolif. 36:165-75.
40. Canman CE, et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1677-9.
41. Jiang C, Hu H, Malewicz B, Wang Z, Lu J. (2004) Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol. Cancer Ther. 3:877-84.
42. Lu KW, et al. (2010) Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells. In vivo. 24:287-91.
43. Kahlem P, Dorken B, Schmitt CA. (2004) Cellular senescence in cancer treatment: friend or foe? J. Clin. Invest. 113:169-74.
44. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:1876-83.
45. Bohle A, Jocham D, Bock PR. (2003) Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J. Urol. 169:90-5.